Ensign Peak Advisors
ALT icon

Ensign Peak Advisors’s Altimmune ALT Stock Holding History

Ensign Peak Advisors’s Portfolio ALT Stock Details ALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-454,981
Closed -$3.28M – 1689
2024
Q4 		$3.28M Buy
454,981
+128,204
+39% +$979K 0.01% 766
2024
Q3 		$2.01M Hold
326,777
– – ﹤0.01% 952
2024
Q2 		$2.17M Hold
326,777
– – ﹤0.01% 873
2024
Q1 		$3.33M Hold
326,777
– – 0.01% 766
2023
Q4 		$3.68M Hold
326,777
– – 0.01% 704
2023
Q3 		$850K Hold
326,777
– – ﹤0.01% 1322
2023
Q2 		$1.15M Hold
326,777
– – ﹤0.01% 1149
2023
Q1 		$1.38M Buy
326,777
+232,362
+246% +$2.76M ﹤0.01% 999
2022
Q4 		$1.55M Buy
94,415
+37,115
+65% +$417K ﹤0.01% 909
2022
Q3 		$732K Buy
+57,300
New +$846K ﹤0.01% 1249

Other funds holding ALT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Ensign Peak Advisors's ALT Position: Q1 2025 in Review

Ensign Peak Advisors sold out of Altimmune (ALT) in Q1 2025, closing a stake of 454,981 shares — an estimated $3.28M sold.

Ensign Peak Advisors first reported a position in ALT in Q3 2022 and held it in 10 quarters. The position peaked at $3.68M in Q4 2023. 176 funds tracked by Wall St. Rank hold ALT as of Q1 2025.

  • Ensign Peak Advisors reported no remaining Altimmune position as of Q1 2025 after selling out during the quarter.
  • Ensign Peak Advisors sold 454,981 Altimmune shares in Q1 2025, an estimated $3.28M.
  • Ensign Peak Advisors first reported a position in Altimmune in Q3 2022 and held it in 10 quarters.
  • Ensign Peak Advisors's Altimmune position peaked at $3.68M in Q4 2023.
  • 176 funds tracked by Wall St. Rank held Altimmune as of Q1 2025.

Based on Ensign Peak Advisors's 13F filing for Q1 2025, filed 14 May 2025.